The adverse event profile of pregabalin: A systematic review and meta‐analysis of randomized controlled trials
暂无分享,去创建一个
G. Zaccara | P. Gangemi | L. Specchio | P. Perucca | Gaetano Zaccara | Piero Perucca | Pierfranco Gangemi | Luigi Specchio
[1] P. Whorwell,et al. Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. , 2007, Gut.
[2] J. Davidson,et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial. , 2003, The American journal of psychiatry.
[3] A G Marson,et al. Clobazam as an add-on in the management of refractory epilepsy. , 2008, The Cochrane database of systematic reviews.
[4] C. Elger,et al. Pregabalin Add‐on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible‐dose and Fixed‐dose Treatment in a Double‐blind, Placebo‐controlled Study , 2005, Epilepsia.
[5] Philip J Mease,et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. , 2008, The Journal of rheumatology.
[6] James P. Young,et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin , 2008, PAIN.
[7] R. Fieve,et al. Efficacy of Pregabalin in the Treatment of Generalized Anxiety Disorder: Double-blind, Placebo-Controlled Comparison of BID versus TID Dosing , 2005, Journal of clinical psychopharmacology.
[8] A. Marson,et al. New antiepileptic drugs: a systematic review of their efficacy and tolerability , 1996, BMJ.
[9] M. Versavel,et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial , 2004, Pain.
[10] C. Salzman,et al. Update: New Uses for Lithium and Anticonvulsants , 2007, CNS Spectrums.
[11] M. Versavel,et al. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double‐blind study , 2008, European journal of pain.
[12] S. Kasper,et al. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. , 2006, The Journal of clinical psychiatry.
[13] A. Marson,et al. Zonisamide add-on for drug-resistant partial epilepsy. , 2005, The Cochrane database of systematic reviews.
[14] S. Arroyo,et al. Pregabalin Add‐on Treatment: A Randomized, Double‐blind, Placebo‐controlled, Dose–Response Study in Adults with Partial Seizures , 2004, Epilepsia.
[15] Jason L Salemi,et al. A pilot, double‐blind, placebo‐controlled trial of pregabalin (Lyrica) in the treatment of essential tremor , 2007, Movement disorders : official journal of the Movement Disorder Society.
[16] R. Shrivastava,et al. A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study of Pregabalin in Patients With Generalized Anxiety Disorder , 2003, Journal of clinical psychopharmacology.
[17] M. Brodie. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy , 2010 .
[18] R. Poole,et al. Pregabalin relieves symptoms of painful diabetic neuropathy , 2004, Neurology.
[19] L. Arnold,et al. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. , 2007, Pain medicine.
[20] J. Jankovic,et al. Efficacy and tolerability of pregabalin in essential tremor: A randomized, double-blind, placebo-controlled, crossover trial , 2009, Journal of the Neurological Sciences.
[21] J. Rosenstock,et al. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial , 2008, BMC neurology.
[22] A. Satoa,et al. ehavioral and neurochemical characterization of mice deficient in the N-type a 2 + channel 1 B subunit , 2010 .
[23] P. Ryvlin,et al. Pregabalin for the management of partial epilepsy , 2008, Neuropsychiatric disease and treatment.
[24] William B. Dobyns,et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel , 1997, Nature Genetics.
[25] J. Rosenstock,et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial , 2004, Pain.
[26] M. Rowbotham,et al. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. , 2008, The journal of pain : official journal of the American Pain Society.
[27] M. Rowbotham,et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. , 2005, Arthritis and rheumatism.
[28] M. Pollack,et al. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. , 2005, Archives of general psychiatry.
[29] J. Davidson,et al. Efficacy of the Novel Anxiolytic Pregabalin in Social Anxiety Disorder: A Placebo-Controlled, Multicenter Study , 2004, Journal of clinical psychopharmacology.
[30] B. Uthman,et al. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy , 2005, Neurology.
[31] A. Marson,et al. Zonisamide add-on for drug-resistant partial epilepsy. , 2013, The Cochrane database of systematic reviews.
[32] A. Petralia,et al. P0080 - Efficacy of Pregabalin and Venlafaxine-XR in generalized anxiety disorder: Results of a double-blind, placebo-controlled 8-week trial , 2008, European Psychiatry.
[33] E. Ben-Menachem. Pregabalin Pharmacology and Its Relevance to Clinical Practice , 2004, Epilepsia.
[34] H. Wittchen,et al. Long-term efficacy of pregabalin in generalized anxiety disorder , 2008, International clinical psychopharmacology.
[35] L. Lamoreaux,et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. , 2005, The journal of pain : official journal of the American Pain Society.
[36] K. Tan-No,et al. Behavioral and neurochemical characterization of mice deficient in the N-type Ca2+ channel α1B subunit , 2010, Behavioural Brain Research.
[37] E. Whalen,et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens , 2005, Pain.
[38] P. Ryvlin,et al. Pregabalin in partial seizures: a pragmatic 21‐week, open‐label study (PREPS) , 2010, European journal of neurology.
[39] C. Johannessen Landmark,et al. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. , 2008, CNS drugs.
[40] A. Marson,et al. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review , 2001, Epilepsy Research.
[41] S. Montgomery,et al. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder , 2008, British Journal of Psychiatry.
[42] P. Whorwell,et al. Oesophagogastric fistula: a post-operative complication , 2007, Gut.
[43] R. Poole,et al. Pregabalin for the treatment of postherpetic neuralgia , 2003, Neurology.
[44] J. Shane,et al. PREGABALIN IN CENTRAL NEUROPATHIC PAIN ASSOCIATED WITH SPINAL CORD INJURY: A PLACEBO-CONTROLLED TRIAL , 2007, Neurology.
[45] S. I. Lee,et al. Pregabalin add‐on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: A double‐blind, randomized, placebo‐controlled, multicenter trial , 2009, Epilepsia.
[46] M. H. Vegt,et al. Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen , 2008, PAIN.
[47] A. Marson,et al. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. , 2001, The Cochrane database of systematic reviews.
[48] A. Marson,et al. Vigabatrin for refractory partial epilepsy. , 2008, The Cochrane database of systematic reviews.
[49] C. J. Landmark,et al. Antiepileptic Drugs in Non-Epilepsy Disorders , 2012 .
[50] E. Boyden,et al. Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo , 2008, Proceedings of the National Academy of Sciences.
[51] A. G. Marson,et al. Remacemide for drug-resistant localization related epilepsy. , 2002, The Cochrane database of systematic reviews.
[52] J. V. van Gerven,et al. Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy. , 2007, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[53] J. French,et al. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures , 2003, Neurology.
[54] M. Versavel,et al. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13‐week, randomized trial , 2006, Current medical research and opinion.
[55] A. Marson,et al. Lamotrigine add-on for drug-resistant partial epilepsy. , 2016, The Cochrane database of systematic reviews.
[56] L. Arnold,et al. Randomized , Double-Blinded , Placebo-Controlled onotherapy Trial of Pregabalin in Patients With Fibromyalg esley , 2008 .
[57] P. Siddall,et al. Pregabalin in central neuropathic pain associated with spinal cord injury , 2006, Neurology.
[58] A. Marson,et al. Tiagabine add-on for drug-resistant partial epilepsy. , 2002, The Cochrane database of systematic reviews.
[59] A. Marson,et al. Topiramate add-on for drug-resistant partial epilepsy. , 2008, The Cochrane database of systematic reviews.